KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Capital Leases (2017 - 2025)

Hologic's Capital Leases history spans 13 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Capital Leases fell 27.03% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $8.1 million, down 27.03%, while the annual FY2025 figure was $9.0 million, 26.23% down from the prior year.
  • Capital Leases for Q4 2025 was $8.1 million at Hologic, down from $9.0 million in the prior quarter.
  • Across five years, Capital Leases topped out at $23.6 million in Q1 2021 and bottomed at $8.1 million in Q4 2025.
  • The 5-year median for Capital Leases is $15.8 million (2023), against an average of $15.8 million.
  • The largest annual shift saw Capital Leases soared 31.03% in 2021 before it decreased 27.03% in 2025.
  • A 5-year view of Capital Leases shows it stood at $21.3 million in 2021, then fell by 16.9% to $17.7 million in 2022, then dropped by 16.95% to $14.7 million in 2023, then dropped by 24.49% to $11.1 million in 2024, then fell by 27.03% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Capital Leases are $8.1 million (Q4 2025), $9.0 million (Q3 2025), and $10.1 million (Q2 2025).